This firm-fixed-price purchase order was awarded by the Department of Health and Human Services Food and Drug Administration to CN Bio Innovations LIMITED, a foreign-owned for-profit organization, for a PHYSIO-MIMIX CN BIO ORGAN CHIP EQUIPMENT SYSTEM and four years of preventative maintenance. The total potential value of the contract is $103,934.40. The contract was awarded on September 3, 2020, with a completion date of December 11, 2022. No set-aside was used for this award, which will be...
This is a $1,550,000.00 fixed-price level of effort contract awarded by the Defense Health Agency (DHA) to Critical Innovations LLC, a small business limited liability company. The contract is for the Small Business Innovation Research (SBIR) Phase II project "DHA SBIR PHASE II O2-1681" and has a completion date of December 3, 2021. The contract is designated as a total small business set-aside. Critical Innovations, an ISO 13485:2016 certified medical research and development company,...
This federal contract award is for the supply of medical research implants to the Defense Health Agency (DHA), a defense agency within the U.S. Department of Defense. The prime contractor is Data Sciences International Inc. (DSI), a subsidiary of Harvard Bioscience Inc. that specializes in providing telemetry, respiratory, and software solutions for preclinical physiologic monitoring to support biomedical research. The contract, awarded on December 5, 2024, is a Blanket Purchase Agreement...
This federal contract award, valued at $262,750.00, was issued by the Defense Health Agency (DHA) to Nanoentek America, Inc., a for-profit, foreign-owned company that specializes in biotechnology research equipment and medical devices. The contract is for the acquisition of AD1K-050 R-Slides and the purchase of reagents. It is a firm-fixed-price purchase order with an ultimate completion date of October 30, 2024. The contract does not have a set-aside designation. Nanoentek America, Inc. has a...
<p>The Department of the Navy Bureau of Medicine and Surgery awarded a firm fixed price purchase order to Biosurv International LTD, a woman-owned not-for-profit organization, for $111,650.00 to provide bioinformatics analysis services. The contract does not have a set-aside designation and has a completion date of February 14, 2024. The place of performance is Great Britain, United Kingdom.</p>
The U.S. Defense agency, the Bureau of Medicine and Surgery, awarded a $80,045.00 firm-fixed-price purchase order contract to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company. The contract, identified as N3239824P0044, is for the delivery of P2 INTEGRATED CAPEX and has an ultimate completion date of September 29, 2025. Oxford Nanopore Technologies provides next-generation genomic sequencing equipment, consumables, and associated services to various U.S....
This is a $1,550,000.00 Firm Fixed Price, Definitive Contract awarded by the Defense Health Agency (DHA) to Critical Innovations LLC, a for-profit limited liability company, under the Small Business Innovation Research (SBIR) Program Phase II. The contract is for the development of the "BurRapid Intracranial Access Platform with QuickICP and QuickVentric Attachments" medical research and development project, with a total small business set-aside designation. Critical Innovations LLC is...
This federal contract award is for the provision of HUMAN CELLS OR TISSUES INTENDED FOR IMPLANTATION, TRANSPLANTATION, INFUSION, OR TRANSFER INTO HUMAN RECIPIENT. The contract has a ceiling value of $16,850.00 and was awarded on July 26, 2024, with a final completion date of September 30, 2024. The contract is a firm fixed-price purchase order awarded to Miscellaneous Foreign Awardees, a for-profit organization registered in the System for Award Management (SAM). Miscellaneous Foreign Awardees...
This federal contract award, valued at $75,000.00, was issued by the Uniformed Services University of the Health Sciences, a defense agency, to Emulate Inc. (doing business as Emulate), a biotechnology company specializing in organ-on-chip technology. The contract is for the delivery of 3-dimensional organ-on-chip technology to support the agency's research initiatives. This is a firm fixed-price purchase order contract with an ultimate completion date of August 31, 2020. The contract was not...
This is a $1,100,000.00 Firm Fixed Price contract awarded by the Defense Health Agency (DHA) to Critical Innovations LLC, a small business, under the Small Business Innovation Research (SBIR) program. The contract is for the development of the Pleurapath Thoracostomy System, a medical device for military and pre-hospital healthcare applications. The contract is set to be completed by October 12, 2025. Critical Innovations LLC is a for-profit limited liability company that specializes in...